Abstract
We studied the ability of synthetic single‐stranded 30‐mer oligodeoxyribonucleotides oligoDNAs) with three different kinds of hexamer palindromic sequence to induce interferon (IFN) production of human peripheral blood lymphocytes (PBL). When PBL was cultured with oligoDNA having a palindrome of AACGTT or GACGTC, IFN activity was detected by bioassay in the culture fluid after 8 h, and the amount of IFN reached the maximum after 18 h. IFN‐α was predominantly produced, and small amounts of IFN‐β and IFN‐γ were also found. OligoDNA with the palindrome ACCGGT had no effect.
Keywords: Synthetic oligoDNA, IFN production, Human PBL, Palindrome
Full Text
The Full Text of this article is available as a PDF (261.2 KB).
REFERENCES
- 1. ) Mashiba , H. , Matsunaga , K. , Tomoda , H. , Furusawa , M. , Jimi , S. and Tokunaga , T.In vitro augmentation of NK activity of peripheral blood cells from cancer patients by a DNA fraction from M . bovis BCG. Jpn. J. Med. Sci Biol. , 41 , 197 – 202 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Ochiai , T. , Suzuki , T. , Nakajima , K. , Asano , T. , Mukai , M. , Touzu , T. , Okuyama , K. , Isono , K. , Nishijima , H. and Ohkawa , M.Studies on lymphocyte subsets of regional lymph nodes after endoscopic injection of biological response modifiers in gastric cancer patients . Int. J. Immunother. , 2 , 259 – 265 ( 1986. ). [Google Scholar]
- 3. ) Ishihara , K. , Ikeda , S. and Furue , H.Late‐stage phase‐II clinical study of MY‐1 in treatment on malignant cutaneous tumors . Skin Cancer , 5 , 458 – 468 ( 1990. ) ( in Japanese ). [Google Scholar]
- 4. ) Tokunaga , T. , Yamamoto , H. , Shimada , S. , Abe , H. , Fukuda , T. , Fujisawa , Y. , Furutani , Y. , Yano , O. , Kataoka , T. , Makiguchi , N. and Suganuma , T.Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity . J. Natl, Cancer Inst. , 72 , 955 – 962 ( 1984. ). [PubMed] [Google Scholar]
- 5. ) Shimada , S. , Yano , O. , Inoue , H. , Kuramoto , E. , Fukuda , T. , Yamamoto , H. , Kataoka , T. and Tokunaga , T.Antitumor activity of deoxyribonucleic acid from Mycobacterium bovis BCG. II. Effects on various syngeneic mouse tumors . J. Natl, Cancer Inst , 74 , 681 – 688 ( 1985. ). [PubMed] [Google Scholar]
- 6. ) Shimada , S. , Yano , O. and Tokunaga , T.In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG . Jpn. J. Cancer Res. , 77 , 808 – 816 ( 1986. ). [PubMed] [Google Scholar]
- 7. ) Yamamoto , S. , Kuramoto , E. , Shimada , S. and Tokunaga , T.In vitro augmentation of natural killer cell activity and production of interferon‐α/β and ‐γ with deoxyribonucleic acid fraction from Mycobacterium bovis BCG . Jpn. J. Cancer Res. , 79 , 866 – 873 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. ) Kuramoto , E. , Toizumi , S. , Shimada , S. and Tokunaga , T.In situ infiltration of natural killer cells induced by intradermal injection of the nucleic acid fraction from BCG . Microbiol. Immtmol , 33 , 929 – 940 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Tokunaga , T. , Yano , O. , Kuramoto , E. , Kimura , Y. , Yamamoto , T. , Kataoka , T. and Yamamoto , S.Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells . Microbiol. Immunol , 36 , 55 – 66 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Thole , J. E. R. , Keulen , W. J. , Kolk , A. H. J. , Groothuis , D. G. , Berwald , L. G. , Tiesjewa , R. H. and Embdes , D. A.Characterization, sequence determination and immunogenicity of a 64 kilodalton protein of Mycobacterium bovis BCG expressed in E. coli K 12 . Infect. Immun. , 55 , 1466 – 1475 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. ) Radford , A. J. , Duffield , B. J. and Plackett , P.Cloning of a species‐specific antigen of Mycobacterium bovis . Infect. Immun. , 56 , 921 – 925 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. ) Matsuo , K. , Yamaguchi , R. , Yamazaki , A. and Tasaka , H.Cloning and expression of the Mycobacterium bovis BCG gene for extracellular antigen . J. Bacteriol , 170 , 3847 – 3854 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. ) Kataoka , T. , Yamamoto , S. , Yamamoto , T. , Kuramoto , E. , Kimura , Y. , Yano , O. and Tokunaga , T.Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG . Jpn. J. Cancer Res. , 83 , 244 – 247 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. ) Yamamoto , S. , Yamamoto , T. , Kataoka , T. , Kuramoto , E. , Yano , O. and Tokunaga , T.Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN‐mediated natural killer activity . J. Immunol , 148 , 4072 – 4076 ( 1992. ). [PubMed] [Google Scholar]
- 15. ) Yamamoto , T. , Yamamoto , S. , Kataoka , T. and Tokunaga , T.Ability of oligonucleotides with certain palindromes to induce IFN production and augment NK activity is associated with their base length . Antisense Res, Dev. , 4 , 119 – 122 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Kohase , M. , Kohno , S. , Yamazaki , S. , Shishido , A. and Kono , R.Potency standardization of human interferon preparation for clinical trials . In“The Clinical Potency of Interferons,” ed. Kono R. and Vilcek J. , pp. 299 – 309 ( 1982. ). University of Tokyo Press; , Tokyo . [Google Scholar]
- 17. ) Bennett , R. M. , Gabor , Q. T. and Merritt , M. M.DNA binding to human leukocytes. Evidence for receptormediated association, internalization, and degradation of DNA . J. Clin. Invest. , 76 , 2182 – 2190 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. ) Yakubov , L. A. , Deeva , E. A. , Zarytova , V.P. , Ivanova , E. M. , Ryte , A. S. , Yurchenko , L. V. and Vlassov , V. V.Mechanism of oligonucleotide uptake by cells: involvement of specific receptors ? Proc. Natl. Acad. Sci. USA , 86 , 6454 – 6458 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. ) Kodama , T. , Freeman , M. , Rohre , L. , Zabrecky , J. , Matsudaira , P. and Krieger , M.Type I macrophage scavenger receptor contains alpha‐helical and collagen‐like coiled coils . Nature , 343 , 531 – 535 ( 1990. ). [DOI] [PubMed] [Google Scholar]